The Goodwin Lab Excellence and Innovation in Spine Tumors Basic Science
  • Genetic predictors and cellular mechanisms of
    metastatic spine disease
  • Functional consequences of disease recurrence
    and progression.
Clinical Care
  • Focusing on advancement in spine tumor management
  • Experience in spine tumor surgery and stereotactic radiosurgery
Clinical Research
  • Predictors of Health-Related Quality of Life (HRQOL) and clinical outcomes for spine tumor patients.
  • Sociodemographic disadvantage in spine tumor outcomes.
  • Spinopelvic parameters in metastatic and primary tumors.
  • Identifying optimal therapeutic interventions and prognostic factors for spine tumor patients.
Academic
Collaboration and
Scholarship
  • Multi-institutional Research Studies and Collaborations.
  • Lab-awarded research grants and fellowships.
  • National and International presentations.

Get in Touch!

Have a question? Let us know how we can help!

Meet Our Team

Our TEAM aims to find the best predictors, interventions, and treatments to improve the quality and quantity of life for patients diagnosed with spine tumors and other neurosurgical diseases.

Patient Resources

Our TEAM aims to provide the best clinical care that is consistent with the goals and values of each patient.

Excellence and Innovation in Spine Tumors

Our team’s focus is to provide prompt access to the latest and most advanced treatment options for patients.

Our lab investigates genetic predictors and cellular mechanisms of metastatic progression to the bone and spine, as well as the functional consequences of disease recurrence and progression.

Take a look at a few of our most recent key publications.

Our mission is to fund-raise and organize mission trips to West Africa…

Learn more about the Duke Department of Neurosurgery and how we work together.

Patient Stories

Read real stories from real patients.

BreakThroughs Magazine

Read the BreakThroughs Magazine to learn how the Center for Brain and Spine Metastatis started.

Spine Metastasis of the DCI

Read the Duke Cancer Institute 2019 report to see another patient story!

Clinical Research

We are investigating predictors of Health-Related Quality of Life (HRQOL) and clinical outcomes in patients diagnosed with spinal tumors.

Dr. Rory Goodwin

C. Rory Goodwin is the Director for Spinal Oncology, Surgical Director for the Duke Center for Brain and Spine Metastasis and an Assistant Professor at the Duke University Medical Center. Dr. Goodwin attended the University of Florida where he majored in Neurobiological Sciences and Business Administration with minors in Chemistry and Economics.

Research

My lab investigates genetic predictors and cellular mechanisms of metastatic progression to the bone and spine.

Recent Publications

Association of neurologic deficits with surgical outcomes and health-related quality of life after treatment

Patient Story

Learn how Dr. Goodwin helped heal a past patient with metastatic cancer.

Clinical

Exerci tation ullamcorper suscipitorens lobortis nisl ut aliquip ex ea commodo non habent claritatem.

Symptoms

Symptoms can vary from patient to patient and are in general dependent on the size and location of a spine tumor.

Brain & Spine

The Duke Center for Brain and Spine Metastasis is the most comprehensive destination program...

Diagnosia

Whether diagnosed with a spine tumor or experiencing symptoms that suggest a spine tumor, a CT, MRI...

Treatment

Certain spine tumors are only observed, while others are treated with medications, radiation or surgery.

Teamwork

Our TEAM aims to create a family-centered environment. Our TEAM aims to cultivate a creative, productive, professional and friendly environment that will invest in themselves and future researchers.

EEG0%
Vascular0%
Surgery0%
67

Medical Research

73

Cardiology

52

Primary Care

80

Travel Medicine

Recent Publications

Importance of Spinal Alignment in Primary and Metastatic Spine Tumors. Sankey EW, Park C, Howell EP, Pennington Z, Abd-El-Barr M, Karikari IO, Shaffrey CI, Gokaslan ZL, Sciubba D, Goodwin CR.World Neurosurg. 2019 Dec;132:118-128. doi: 10.1016/j.wneu.2019.08.161. Epub 2019 Aug 30.PMID: 31476476

Association of neurologic deficits with surgical outcomes and health-related quality of life after treatment for metastatic epidural spinal cord compression. Barzilai O, Versteeg AL, Goodwin CR, Sahgal A, Rhines LD, Sciubba DM, Schuster JM, Weber MH, Lazary A, Fehlings MG, Clarke MJ, Arnold PM, Boriani S, Bettegowda C, Gokaslan ZL, Fisher CG, Laufer I; AOSpine Knowledge Forum Tumor.Cancer. 2019 Dec 1;125(23):4224-4231. doi: 10.1002/cncr.32420. Epub 2019 Aug 13.PMID: 31410854

Total en bloc resection of primary and metastatic spine tumors. Howell EP, Williamson T, Karikari I, Abd-El-Barr M, Erickson M, Goodwin ML, Reynolds J, Sciubba DM, Goodwin CR.Ann Transl Med. 2019 May;7(10):226. doi: 10.21037/atm.2019.01.25.PMID: 31297391

Have a question?

Let us know how we can help!